Part of the team of researchers at IRB BarcelonaInstitute for Research in Biomedicine (IRB Barcelona)
ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15R...Impact Journals LLC